Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Regional Native American Community Networks Program (RNACNP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02843217
Recruitment Status : Completed
First Posted : July 25, 2016
Last Update Posted : October 15, 2018
Sponsor:
Information provided by (Responsible Party):
Dedra Buchwald, Washington State University

Brief Summary:

Aim: Determine the overall effectiveness of a targeted digital messaging intervention at improving colorectal cancer (CRC) screening rates compared to care as usual.

Hypothesis: Screening rates will be higher for patients who receive the digital messaging intervention, compared to the control group in which patients receive care as usual.


Condition or disease Intervention/treatment Phase
Colorectal Cancer Behavioral: Lifestyle, screening Not Applicable

Detailed Description:

Native People for Cancer Control is one of the projects under Partnerships for Native Health, and is 1 of 23 Community Networks Programs funded by the National Cancer Institute. The aim of Native People for Cancer Control is to reduce cancer health disparities by conducting training, research, education and outreach, in collaboration with American Indian and Alaska Native communities. We do this work in partnership with Native people, communities, and organizations in an 8-state area, including: Alaska, Washington, Wyoming, Oregon, Idaho, Montana, North Dakota, and South Dakota. Our program consists of 4 cores:

Administrative Core: assists with grant administration, budgeting, sub-contracts with Tribes, program planning, and reporting.

Outreach/Education Core: assists with cancer education, outreach, health promotion, and cancer prevention activities among urban and rural AI/AN people.

Training Core: builds capacity for Native faculty-level investigators, and students, to conduct research.

Research Core: conducts community-based participatory research on colorectal cancer screening, health literacy, health communication, and cancer risk factors among American Indian and Alaska Native people.

The main research project under Native People for Cancer Control is titled, "Innovations in Enhancing Colorectal Cancer Screening". The goal of this project is to develop, implement, and evaluate a community wide, multi-media campaign to improve colorectal cancer screening among American Indians and Alaska Natives in 3 communities.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Intervention Model: Crossover Assignment
Primary Purpose: Screening
Official Title: Innovations in Enhancing Colorectal Cancer Screening
Study Start Date : September 2010
Actual Primary Completion Date : August 2015
Actual Study Completion Date : August 2015

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Text Messaging Behavioral: Lifestyle, screening



Primary Outcome Measures :
  1. Colorectal Cancer Screening, beginning age 50 [ Time Frame: 9 month intervention ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   50 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • AI/AN
  • Age 50-75
  • Active clinical patient

Exclusion Criteria:

  • Not AI/AN

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02843217


Locations
Layout table for location information
United States, Washington
Washington State University
Pullman, Washington, United States, 99164-4820
Sponsors and Collaborators
Washington State University
Layout table for additonal information
Responsible Party: Dedra Buchwald, Human Subjects Protection Manager, Washington State University
ClinicalTrials.gov Identifier: NCT02843217    
Other Study ID Numbers: U54CA153498 ( U.S. NIH Grant/Contract )
First Posted: July 25, 2016    Key Record Dates
Last Update Posted: October 15, 2018
Last Verified: June 2016

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases